11/14/2024
11:19 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Inozyme Pharma (Subject)
| Form SC 13G/A | |
11/05/2024
7:33 AM | Inozyme Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
7:31 AM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:34 PM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Inozyme Pharma (Subject)
| Form SC 13G | |
10/03/2024
7:58 PM | Inozyme Pharma (Issuer)
Treco Douglas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:57 PM | Inozyme Pharma (Issuer)
Winton Matthew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/06/2024
3:52 PM | Inozyme Pharma (Filer)
| Form 424B5 | |
08/06/2024
3:54 PM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:30 PM | Inozyme Pharma (Issuer)
Mathers Edward T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:15 PM | Hopfner Robert Lorne (Reporting)
Inozyme Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:20 PM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:32 AM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:33 AM | Inozyme Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/08/2024
5:44 AM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
4:23 PM | Inozyme Pharma (Issuer)
Winton Matthew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:23 PM | Inozyme Pharma (Issuer)
Treco Douglas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
7:30 AM | Inozyme Pharma (Issuer)
Subramanian Sanjay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
7:30 AM | Inozyme Pharma (Issuer)
Treco Douglas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
7:30 AM | Inozyme Pharma (Issuer)
Winton Matthew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:34 AM | Inozyme Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/12/2024
7:40 AM | Inozyme Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2024
7:32 AM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
6:11 PM | Inozyme Pharma (Subject)
Sofinnova Venture Partners X, L.P. (Filed by)
| Form SC 13D/A | |
02/14/2024
7:34 PM | Inozyme Pharma (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
5:08 PM | Inozyme Pharma (Subject)
New Enterprise Associates 15, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
12:40 PM | Inozyme Pharma (Subject)
SAMLYN CAPITAL, LLC (Filed by)
| Form SC 13G | |
02/14/2024
10:54 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Inozyme Pharma (Subject)
| Form SC 13G | |
02/14/2024
7:48 AM | Deep Track Capital, LP (Filed by)
Inozyme Pharma (Subject)
| Form SC 13G/A | |
02/12/2024
8:06 PM | Inozyme Pharma (Subject)
Pivotal bioVenture Partners Fund I, L.P. (Filed by)
| Form SC 13D/A | |
02/07/2024
6:46 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Inozyme Pharma (Subject)
| Form SC 13G/A | |
02/05/2024
8:12 AM | Inozyme Pharma (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G/A | |
